2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxaldehyde,
EXP 132,
EXP 3179,
EXP-132,
EXP-3179,
EXP132,
EXP3179,
Losartan Carboxaldehyde,
114798-36-6,
UNII-KJ52CU0VV6,
KJ52CU0VV6,
CHEMBL308493,
E-3179,
1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazole-5-carbaldehyde,
DUP 167,
EXP 3179,
2-Butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-5-carbaldehyde,
1H-Imidazole-5-carboxaldehyde, 2-butyl-4-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-,
losartancarbaldehyde,
1H-Imidazole-5-carboxaldehyde, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-carbaldehyde,
EXP-3179,
Losartan potassium specified impurity K [EP],
SCHEMBL860,
CTK8E7662,
DTXSID80150855,
FQZSMTSTFMNWQF-UHFFFAOYSA-N,
ZINC1552042,
BDBM50211282,
AKOS030525231,
API0000634,
TRA0005533,
RT-013598,
FT-0670857,
L001962,
J-003136,
2-butyl-4-chloro-5-formyl-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylimidazole,
2-butyl-5-chloro-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbaldehyde,
2-butyl-4-chloro-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carbaldehyde,
2-Butyl-4-chloro-1-[[2 inverted exclamation mark -(1H-tetrazol-5-yl)[1,1 inverted exclamation mark -biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxaldehyde,
2-butyl-4-chloro-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-carbaldehyde,
DUP-167,
Losartan Potassium EP Impurity K,
CID9802264,
2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbaldehyde,